4th Quarter - Report
POLSINELLI PC for BRACCO DIAGNOSTICS, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to FDAs authority to regulate products as drugs and medical devices: S 4348 FDASLA of 2022 HR 7667 Food and Drug Amendments 2022 S 4333 The Clear Act FY 2023 Omnibus Appropriations Bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL M GABA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.